Crossmark

Prescribing trends and spontaneous reporting patterns of adverse drug reactions of ADHD medications in children and adolescents in germany: A retrospective analysis (2013–2022)

Crossref DOI link: https://doi.org/10.1007/s00787-026-03031-5

Published Online: 2026-04-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dubrall, Diana

Reifferscheid, Mona

Egberts, Karin

Fekete, Stefanie

Neubert, Antje

Rock, Hans W

Plener, Paul

Below, Maike

Romanos, Marcel

Schmid, Matthias

Sachs, Bernhardt
Funding

Funding for this research was provided by:

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
License Information

Text and Data Mining valid from 2026-04-27

Version of Record valid from 2026-04-27
More Information

Article History

Received: 23 December 2025

Accepted: 30 March 2026

First Online: 27 April 2026

Declarations

:

: DD and MS are supported by the EVAS project, which is founded by the Federal Institute for Drugs and Medical Devices and the Institute for Medical Biometry, Informatics and Epidemiology at the university hospital Bonn. PLP has received speaker honoraria from GSK, Janssen, Medice, Consilium, infectopharm, and Oral B. None of the authors has any commercial association that may pose a conflict of interest in connection with the submitted manuscript.

: Not applicable

Document is current

Any future updates will be listed below